Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer
- Authors
- Shim, Jung-In; Ryu, Ji-Yoon; Jeong, Soo Young; Cho, Young-Jae; Choi, Jung-Joo; Hwang, Jae Ryoung; Choi, Ju-Yeon; Sa, Jason K.; Lee, Jeong-Won
- Issue Date
- May-2022
- Publisher
- Academic Press
- Keywords
- Olaparib; 5-AZA; Epithelial ovarian cancer; Patient-derived xenograft; Animal model
- Citation
- Gynecologic Oncology, v.165, no.2, pp 270 - 280
- Pages
- 11
- Indexed
- SCIE
SCOPUS
- Journal Title
- Gynecologic Oncology
- Volume
- 165
- Number
- 2
- Start Page
- 270
- End Page
- 280
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61219
- DOI
- 10.1016/j.ygyno.2022.03.005
- ISSN
- 0090-8258
1095-6859
- Abstract
- Objective
Poly (ADP)-ribose polymerase inhibitors (PARPi) are effective clinical agents for treatment of epithelial ovarian cancer (EOC) harboring BRCA mutations as well as those without BRCA mutations. In this study, we evaluate the efficacy of combined PARPi and DNA methyltransferase inhibitor (DNMTi) in EOCs.
Methods
Expression levels of DNMT1 and PARP1 proteins in EOC cells were assessed using western blot analysis and immunohistochemistry. To evaluate the effects of co-treatment of PARPi (olaparib) and DNMTi (5-azacitidine, 5-AZA), we performed cell proliferation, apoptosis, and wound-healing assays in EOC cells. In addition, we performed in vivo experiments using both cell-line and patient-derived xenograft (PDX) models of EOC.
Results
The combination of olaparib and 5-AZA significantly inhibited cell proliferation and migration and induced apoptosis compared with olaparib or 5-AZA alone in EOC cell lines including A2780, HeyA8, A2780-CP20, and HeyA8-MDR. Moreover, in vivo experiments with this combination showed significantly decreased weight and nodule numbers of tumors in cell-line xenograft models with A2780 cells and a PDX model compared with control, olaparib, and 5-AZA groups. As a potential mechanism, the expression of intracellular reactive oxygen species (ROS) and its related proteins, including p-ERK, NRF2, p-p38, HO-1, and γH2AX, was affected in EOC cells.
Conclusions
Co-treatment with PARPi and DNMTi had a significant anti-tumor effect in EOC cells. This combination might be a potential therapeutic strategy for EOCs.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 3. Graduate School > Biomedical Research Center > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.